Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference61 articles.
1. Psarras A, Emery P, Vital EM. Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy. Rheumatology (Oxford). 2017;56(10):1662–75.
2. Lichtman EI, Helfgott SM, Kriegel MA. Emerging therapies for systemic lupus erythematosus–focus on targeting interferon-alpha. Clin Immunol. 2012;143(3):210–21.
3. Ramaswamy M, Tummala R, Streicher K, Noqueria da Costa A, Brohawn P. The pathogenesis, molecular mechanisms, and therapeutic potential of the interferon pathway in systemic lupus erythematosus and other autoimmune diseases. Int J Mol Sci. 2021;22(20):11286.
4. Bengtsson AA, Rönnblom L. Role of interferons in SLE. Best Pract Res Clin Rheumatol. 2017;31(3):415–28.
5. Khamashta M, Merrill JT, Werth VP, Furie R, Kalunian K, Illei GG, et al. Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2016;75(11):1909–16.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献